[ad_1] NEW YORK, Sept. 16, 2024 /PRNewswire/ — Lument Finance Trust, Inc. (NYSE: LFT) (“LFT” or the “Company”) announced the declaration of a cash dividend of $0.08 per share of common stock with respect to the third […]
Tag: Inc.
First Financial Bankshares Announces the Election of Brian D. Goodrich, EVP, General Counsel
[ad_1] ABILENE, Texas, Sept. 16, 2024 /PRNewswire/ — First Financial Bankshares, Inc. (NASDAQ: FFIN) (the “Company,” “First Financial Bankshares,” “we”, “us” or “our”) has announced the election of Brian D. Goodrich as Executive Vice President and […]
Akeso’s Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
[ad_1] HONG KONG, Sept. 16, 2024 /PRNewswire/ — At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) published the phase 2 results from its ivonescimab in combination with chemotherapy as a first-line […]
Broadridge’s Securities-based Lending Capabilities and Wealth Lending Network Now Integrated with Morningstar Advisor Workstation
[ad_1] The collaboration enables independent advisors to deliver holistic advisory services across the full balance sheet with integrated SBL capabilities to see the borrowing power for portfolios. NEW YORK, Sept. 15, 2024 /PRNewswire/ — Global […]
Akeso Published First-Ever Efficacy Data for PD-1/VEGF Bispecific Antibody Ivonescimab with or without CD47 Antibody plus FOLFOXIRI for mCRC at ESMO 2024
[ad_1] HONG KONG, Sept. 15, 2024 /PRNewswire/ — At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) presented efficacy data for the first time for its internally developed PD-1/VEGF bispecific antibody, ivonescimab, with […]
